(PharmaNewsWire.Com, December 22, 2017 ) Septic Arthritis Market Information: By Diagnosis (Joint Fluid Analysis, Blood Tests, Imaging), Treatment (Antibiotics, Surgery), Indication (Arthritis, Diabetes,), End User (Orthopedic Hospitals, Clinics, Diagnostic Centers) - Global Forecast till 2023 The Global Septic Arthritis Market is expected to grow at a CAGR of 7.5% during the forecast period. Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include redness, heat, and pain in the joints reducing their movement. It is caused by bacteria, viruses, fungi, and parasites. Diabetes, osteoarthritis, gout, rheumatoid arthritis, joint trauma and poor immune function are major risk factors for septic arthritis. The market for septic arthritis is driven by an increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, availability of cost effective treatment and extensive research and development activities in internal medicine. There is an increasing demand for the new drugs for the treatment of septic arthritis which further fuels the growth of the market. Bacterial resistance to commonly used antibiotics such as vancomycin may restrain for the growth of the market. Fierce competition among key market players acts as a barrier for the new entrants in the market.
Key Players in the Global Septic Arthritis Market Some of the key players in this market are Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.). Segments The global septic arthritis market is segmented on the basis of diagnosis, treatment, indication, and end user. On the basis of diagnosis, market is segmented into joint fluid analysis, blood tests, imaging and others. Imaging is further segmented into X-ray, ultrasonography, MRI, and CT scan. On the basis of treatment, the market is segmented into antibiotics, aspiration of the joint, surgery, and others. Surgery is further segmented into arthrotomy and arthroscopy. On the basis of indication, the market is segmented into arthritis, hip or knee prosthesis, poor immune function, joint surgery, and others. On the basis of end user, the market is segmented into orthopedic hospitals, clinics, pharmaceutical companies, and others.
Regional Analysis of the Global Septic Arthritis Market America is the largest market for septic arthritis owing to the rising prevalence of septic arthritis in the U.S., According to the Center for Disease Control and Prevention, an estimated 78 million (26%) U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Furthermore, arthritis prevalence was the highest among people 65 years and older, women, and obese population. Europe is the second largest market for septic arthritis owing to the rising prevalence of rheumatoid arthritis in European countries and availability of funds for research and development activities. The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing geriatric population, rising prevalence of chronic disease such as diabetes, and obesity, and changing lifestyles of the people. Diabetes is one of the major problems further creating opportunities for the market growth. The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases. Continue… We are thankful for the support and assistance from Septic Arthritis Market Research Report - Global Forecast till 2023 chain related technical experts and marketing experts during Research Team survey and interviews. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact: Akash Anand, Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India +1 646 845 9312 Email: akash.anand@marketresearchfuture.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
